Form 4: Lilly Endowment Disposes 112,596 Eli Lilly Shares
Rhea-AI Filing Summary
Lilly Endowment Inc. reported the sale of 112,596 shares of Eli Lilly & Co. (LLY) common stock on 10/02/2025. The Form 4 lists multiple sale (S) transactions with weighted-average prices reported per line ranging from about $821.09 to $833.92 and transaction price ranges across the trades between $821.00 and $834.23. After the reported sales, the filing shows the reporting person beneficially owned 95,029,382 shares, held directly. The form is signed by Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc., dated 10/03/2025. The filing provides weighted-average prices and footnotes saying the filer will supply per-price breakdowns on request.
Positive
- Full disclosure of multiple sale transactions with weighted-average prices and offer to provide detailed per-price breakdowns upon request
- Form 4 filed and signed promptly (signature dated 10/03/2025), meeting reporting requirements
Negative
- Insider sold a total of 112,596 shares on 10/02/2025, which is a sizeable absolute disposition
- Prices ranged broadly between $821.00 and $834.23, indicating the sales occurred across multiple executions
Insights
Insider sale of 112,596 LLY shares disclosed; filer remains a very large direct holder.
The Form 4 shows multiple sale transactions on 10/02/2025 totaling 112,596 shares, executed at weighted-average prices reported per line between $821.09 and $833.92. The filing confirms the shares are held directly and that the reporting person beneficially owned 95,029,382 shares after the sales.
This disclosure fulfills Section 16 reporting obligations and provides price ranges and weighted averages; the filer also offers to provide transaction-level price breakdowns on request, which improves traceability of the sales. No options or derivative transactions are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 101,112 | $821.088 | $83.02M |
| Sale | Common Stock | 5,214 | $822.346 | $4.29M |
| Sale | Common Stock | 1,540 | $823.601 | $1.27M |
| Sale | Common Stock | 205 | $824.099 | $169K |
| Sale | Common Stock | 1,715 | $826.296 | $1.42M |
| Sale | Common Stock | 358 | $828.346 | $297K |
| Sale | Common Stock | 300 | $830.20 | $249K |
| Sale | Common Stock | 887 | $833.029 | $739K |
| Sale | Common Stock | 1,265 | $833.922 | $1.05M |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $821.00 to $821.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $822.00 to $822.84, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $823.00 to $823.91, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $824.0269 to $824.15, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $825.75 to $826.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $828.29 to $828.39, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $832.4959 to $833.4259, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $833.6277 to $834.23, inclusive.
